Sarepta Therapeutics, Inc. (LON:0L35)
London · Delayed Price · Currency is GBP · Price in USD 21.34
-0.38 (-1.76%)
At close: Jan 2, 2026
Sarepta Therapeutics Market Cap
Sarepta Therapeutics has a market cap or net worth of 1.66 billion as of January 2, 2026. Its market cap has decreased by -82.66% in one year.
Market Cap
1.66B
Enterprise Value
1.96B
Revenue
1.80B
Ranking
n/a
PE Ratio
n/a
Stock Price
21.34
Market Cap Chart
Since June 4, 1997, Sarepta Therapeutics's market cap has increased from 43.06M to 1.66B, an increase of 3,743.89%. That is a compound annual growth rate of 13.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 2, 2026 | 1.66B | -1.21% |
| Dec 31, 2025 | 1.68B | -81.94% |
| Dec 31, 2024 | 9.28B | 31.00% |
| Dec 29, 2023 | 7.08B | -24.98% |
| Dec 30, 2022 | 9.44B | 63.02% |
| Dec 31, 2021 | 5.79B | -41.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.77B |
| GSK plc | 73.48B |
| Haleon | 32.96B |
| Smith & Nephew | 10.35B |
| Convatec Group | 4.67B |
| Hikma Pharmaceuticals | 3.37B |
| HUTCHMED (China) | 1.75B |
| Genus | 1.70B |